- Two individuals offload Poonawalla Fincorp shares worth Rs 120 cr
- No let-up in market sell-off as recession fears build for world economies
- Corporate profit-to-GDP ratio attains 11-year high of 4.3% in FY22
- Rupee hits fresh all-time low vs dollar as US rate hike worries deepen
- Rupee falls by 27 paise to new low of 78.40 against dollar as FIIs exit
- Rupee set to weaken beyond 80 per dollar due to rising crude prices: BofA
- This Rakesh Jhunjhunwala-owned stock hits new low; tanks 34% from IPO price
- Elecon Engineering hits over 14-year high; stock zooms 83% in 3 months
- BoI, PNB, IOB: 5 PSBs form 'falling knife' pattern; charts say stay away
- 5 reasons why BofA Securities has cut year-end Nifty target to 14,500
Indices end at record high for 2nd day, Sensex gains 680 pts, tops 43K
All that happened in the markets today.
Topics
Markets | TCS | Inox Leisure
SI Reporter |
Last Updated at November 10, 2020 17:55 IST
EVENT HIGHLIGHTS
Extending their gaining streak into the seventh session in a row, the benchmark indices gained over 1 per cent to settle at record high levels for the second consecutive session on Tuesday. Investor sentiment got a major boost after Pfizer said its experimental Covid-19 vaccine was more than 90 per cent effective based on initial trial results.
The S&P BSE Sensex topped the crucial 43,000 level to settle at 43,278, up 680 points, or 1.6 per cent while NSE's Nifty added 170 points, or 1.36 per cent to end the session at 12,631 levels. India VIX today gained over 7 per cent to 21.57 levels.
HDFC, HDFC Bank, ICICI Bank, and Reliance Industries (RIL) were the major contributors to the Sensex's gain today.
The broader market, however, continued to underperform. The S&P BSE MidCap index ended 0.10 per cent lower at 15,544 levels while the S&P BSE SmallCap index settled at 15,232, down 0.48 per cent.
On the sectoral front, technology and pharma stocks slipped in the trade. The Nifty IT fell nearly 4 per cent to 20,978.50 levels while Nifty Pharma declined over 4 per cent to 11,168.90 levels.
Global markets
HDFC, HDFC Bank, ICICI Bank, and Reliance Industries (RIL) were the major contributors to the Sensex's gain today.
The broader market, however, continued to underperform. The S&P BSE MidCap index ended 0.10 per cent lower at 15,544 levels while the S&P BSE SmallCap index settled at 15,232, down 0.48 per cent.
On the sectoral front, technology and pharma stocks slipped in the trade. The Nifty IT fell nearly 4 per cent to 20,978.50 levels while Nifty Pharma declined over 4 per cent to 11,168.90 levels.
Global markets
Most Asian share markets rose on Tuesday as global investors applauded successful trial data for a coronavirus vaccine, although expected delays to any mass roll-out took the gloss off early gains.
Japan's Nikkei 225 ended up nearly 0.3 per cent after being 1.1 per cent higher in early trading, touching a 29-year high.
In Europe, shares hovered at eight-month highs.
In commodities, oil prices rose as high hopes that a Covid-19 vaccine could be on the horizon were enough to cancel out fears that fuel demand is set to weaken in the near term. Gold jumped more than 1 per cent, following a sharp slide in the last session.
(With inputs from Reuters)
CATCH ALL THE LIVE UPDATES

Load More